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Abstract
Poor disease-free and overall survival rates in locally advanced cervical cancer are associated with a tumor micro-
environment characterized by extensive hypoxia, interstitial hypertension, and high lactate concentrations. The po-
tential of gadolinium diethylenetriamine pentaacetic acid–based dynamic contrast-enhanced magnetic resonance
imaging (DCE-MRI) in assessing the microenvironment and microenvironment-associated aggressiveness of cer-
vical carcinomas was investigated in this preclinical study. CK-160 and TS-415 cervical carcinoma xenografts were
used as tumor models. DCE-MRI was carried out at 1.5 T, and parametric images of K trans and ve were produced by
pharmacokinetic analysis of the DCE-MRI series. Pimonidazole was used as a marker of hypoxia. A Millar catheter
was used to measure tumor interstitial fluid pressure (IFP). The concentrations of glucose, adenosine triphosphate
(ATP), and lactate were measured by induced metabolic bioluminescence imaging. High incidence of lymph node
metastases was associated with high hypoxic fraction and high lactate concentration in CK-160 tumors and with
high IFP and high lactate concentration in TS-415 tumors. Low K trans was associated with high hypoxic fraction,
low glucose concentration, and high lactate concentration in tumors of both lines and with high incidence of
metastases in CK-160 tumors. Associations between ve and microenvironmental parameters or metastatic propen-
sity were not detected in any of the tumor lines. Taken together, this preclinical study suggests that K trans is a
potentially useful biomarker for poor outcome of treatment in advanced cervical carcinoma. The possibility that
K trans may be used to identify patients with cervical cancer who are likely to benefit from particularly aggressive
treatment merits thorough clinical investigations.
Translational Oncology (2013) 6, 607–617
Introduction
Locally advanced squamous cell carcinoma of the uterine cervix is
treated with radiation alone or radiation in combination with chemo-
therapy and/or surgery. The recommended treatment in the western
world is concurrent cisplatin-based chemotherapy and radiation
therapy [1,2]. The overall survival after concurrent radiochemotherapy
is ∼70%, which is ∼10% higher than that after radiation therapy
alone [3]. The addition of chemotherapy to radiation therapy causes
increased side effects, particularly hematological and gastrointestinal
toxicities [3]. Novel biomarkers that can predict the outcome of radia-
tion therapy of locally advanced cervical cancer are highly warranted for
establishing procedures for personalized treatment [3,4].
The most important tumor-related prognostic factors in cervical
cancer are tumor size, stage, cell type, and lymph node involvement
[4]. Cervical carcinomas develop an abnormal physiological micro-
environment during growth characterized by hypoxia, interstitial hyper-
tension, high lactate concentrations, low glucose concentrations, and
energy deprivation [5,6]. During the last decade, it has become
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increasingly clear that the prognostic and predictive value of these abnor-
malities may be significant. Thus, extensive hypoxia in the primary
tumor has been shown to be associated with locoregional treatment
failure and poor disease-free and overall survival rates in patients with
advanced disease [7–10], and studies of patients with cervical cancer
treated with radiation therapy alone have shown that high interstitial
fluid pressure (IFP) in the primary tumor is linked to high probability
of pelvic recurrence and distant metastases [11–13]. Moreover, the
disease-free and overall survival rates have been shown to be particularly
poor for patients with cervical cancer with high lactate concentrations
in the primary tumor [14,15]. Interestingly, Fyles et al. [12] have mea-
sured both IFP and oxygen tension in the primary tumor of more than
100 patients with advanced cervical carcinoma, and this study showed
no correlation between either IFP or hypoxic fraction and established
tumor-related prognostic factors.
Useful biomarkers for personalized treatment of locally advanced
cervical cancer should most likely reflect the physiological micro-
environment of the tumor tissue [4]. There is significant evidence
from preclinical studies that dynamic contrast-enhanced magnetic
resonance imaging (DCE-MRI) with gadolinium diethylenetriamine
pentaacetic acid (Gd-DTPA) as contrast agent may have the poten-
tial to provide microenvironment-associated tumor biomarkers [16].
A DCE-MRI–based method is particularly attractive in patients with
cervical cancer, because DCE-MRI is an established and commonly
used method for anatomic characterization of the tumor tissue in
these patients. Initial investigations of the prognostic value of DCE-
MRI in cervical cancer have provided interesting results [17,18].
Significant correlations have been found between DCE-MRI–derived
parameters and local tumor control, disease-free survival, and/or over-
all survival [19–23]. Highly different protocols were used for image
acquisition and analysis in these investigations, and consequently,
comparisons of observations are difficult. However, apparently
conflicting results have been reported. In some studies, DCE-MRI
parameters reflecting high angiogenic activity and blood perfusion
were found to be indicative of poor prognosis [20,21], whereas poor
prognosis was reported to be associated with DCE-MRI parameters
reflecting poor vascularization and hypoxia in other studies [22,23].
Few clinical investigations have compared DCE-MRI parameters
with parameters of the physiological tumor microenvironment of
cervical carcinomas [24–26]. Significant correlations have been found
between DCE-MRI–derived parameters and hypoxia-associated
parameters of the tumor tissue, including microvascular density and
oxygen tension [25,26]. However, the correlations are weak, perhaps
because the DCE-MRI was carried out under suboptimal conditions
or because of inadequate analysis of the DCE-MRI series.
In preclinical studies, DCE-MRI can be carried out under well-
controlled conditions, and the physiological microenvironment of
imaged tumors can be assessed in great detail. Experimental tumors
should therefore be useful for investigating whether DCE-MRI may
provide biomarkers for microenvironment-associated poor prognosis
in cancer. The potential of DCE-MRI–derived parametric images as
biomarkers for tumor aggressiveness in cervical cancer was investi-
gated in the present study by using CK-160 and TS-415 cervical
carcinoma xenografts as preclinical models of human disease. The
CK-160 and TS-415 xenograft lines were selected for the study,
because individual tumors of these lines show highly different physio-
logical microenvironments and differ significantly in metastatic pro-
pensity [27]. To search for associations between metastatic propensity
and characteristics of the tumor microenvironment and to investigate
whether DCE-MRI–derived parameters may reflect the microenviron-
ment, tumors were subjected to DCE-MRI and measurement of IFP
before the host mice were killed and the tumors were resected. The
mice were examined for metastatic growth, and the resected tumors
were subjected to immunohistochemical assessment of fraction of
hypoxic tissue and assessment of the concentrations of glucose, ATP,
and lactate by induced metabolic bioluminescence imaging (imBI).
Materials and Methods
Tumor Models
CK-160 and TS-415 human cervical carcinoma xenografts grow-
ing in adult female BALB/c nu/nu mice were used as tumor models
[27]. Tumors were initiated from cells cultured in RPMI 1640 (25 mM
Hepes and L-glutamine) medium supplemented with 13% bovine calf
serum, 250 mg/l penicillin, and 50 mg/l streptomycin. Approximately
5.0 × 105 cells in 10 μl of Hanks’ balanced salt solution were inocu-
lated in the gastrocnemius muscle. Tumors with volumes of 400 to
600 mm3 were included in the study. DCE-MRI and IFP measure-
ments were carried out with mice anesthetized with fentanyl citrate
(0.63 mg/kg), fluanisone (20 mg/kg), and midazolam (10 mg/kg).
Animal care and experimental procedures were in accordance with
the Interdisciplinary Principles and Guidelines for the Use of Animals
in Research, Marketing, and Education (New York Academy of
Sciences, New York, NY).
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
DCE-MRI was carried out as described earlier [28,29]. Briefly,
Gd-DTPA (Schering, Berlin,Germany)was administered in a bolus dose
of 0.3 mmol/kg. T 1-weighted images [repetition time (TR) = 200 ms,
echo time (TE) = 3.2 ms, and αT1 = 80°] were recorded at a spatial
resolution of 0.23 × 0.23 × 2.0 mm3 and a time resolution of 14 sec-
onds by using a 1.5-T whole-body scanner (Signa; General Electric,
Milwaukee, WI) and a slotted tube resonator transceiver coil con-
structed for mice. The coil was insulated with styrofoam to prevent
excessive heat loss from the mice. The body core temperature of the
mice was kept at 37 to 38°C during imaging by using a thermostatically
regulated heating pad. Two calibration tubes, one with 0.5 mM Gd-
DTPA in 0.9% saline and the other with 0.9% saline only, were placed
adjacent to the mice in the coil. The tumors were imaged axially in a
single section through the tumor center by using an image matrix of
256 × 128, a field of view of 6 × 3 cm2, and one excitation. Two proton
density images (TR = 900 ms, TE = 3.2 ms, and αPD = 20°) and three
T 1-weighted images were acquired before Gd-DTPA was adminis-
tered, and T 1-weighted images were recorded for 15 minutes after
the administration of Gd-DTPA. Gd-DTPA concentrations were
calculated from signal intensities by using the method of Hittmair et al.
[30]. The DCE-MRI series were analyzed on a voxel-by-voxel basis by
using the arterial input function of Benjaminsen et al. [31] and the
Tofts pharmacokinetic model [32]. According to this model,
Ct Tð Þ = K
trans
ð1 − HctÞ  ∫
T
0 Ca tð Þ  e −K
transðT −tÞ=veð Þdt;
where C t(T ) is the concentration of contrast agent in the tissue at
time T , C a(T ) is the arterial input function, Hct is the hematocrit,
K trans is the volume transfer constant of the contrast agent, and ve is
the fractional distribution volume of the contrast agent in the tissue
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[32]. Parametric images of K trans and ve were generated from the best
curve fits to plots of C t versus T by using the SigmaPlot software. Our
algorithms produced unphysiological ve values for voxels consisting
primarily of necrotic tissue. Necrotic tissue regions were omitted in
the analysis by excluding voxels with ve < 0.1 and ve > 0.8. Median
values were calculated for the viable tissue of each tumor and used as
parameters for the K trans and ve of individual tumors. Strengths and
limitations of our DCE-MRI method have been discussed else-
where [28,29].
Assessment of IFP
IFP was measured in the tumor center with a Millar SPC 320
catheter equipped with a 2FMikro-Tip transducer (Millar Instruments,
Houston, TX) [33]. The catheter was connected to a computer through
a Millar TC-510 control unit and a preamplifier. Data acquisition was
carried out by using the LabVIEW software (National Instruments,
Austin, TX).
Immunohistochemical Assessment of Fraction of Hypoxic Tissue
1-[(2-Hydroxy-3-piperidinyl)-propyl]-2-nitroimidazole (pimoni-
dazole) was used as a marker of tumor hypoxia [34]. The tumors were
fixed in phosphate-buffered 4% paraformaldehyde, and histologic
sections were prepared by using standard procedures. Immunohisto-
chemistry was performed by using an avidin-biotin-peroxidase–based
staining method [35]. An anti-pimonidazole rabbit polyclonal anti-
body (gift from Professor Raleigh, Department of Radiation Oncol-
ogy, University of North Carolina School of Medicine, Chapel Hill,
NC) was used as primary antibody. Diaminobenzidine was used as
chromogen, and hematoxylin was used for counterstaining. Three
cross sections were examined for each tumor. The area fraction of
the tissue staining positive for pimonidazole was determined by image
analysis and was used as a parameter for hypoxic fraction [34].
imBI of Glucose, ATP, and Lactate Levels
Glucose, ATP, and lactate concentrations were measured in serial
tumor cryosections by the imBI method, as described earlier [36–38].
Briefly, reaction solutions containing specific enzymes linking the
metabolite of interest to the luciferase of Photobacterium fischeri or
Photinus pyralis were used. Light emission was induced in a temperature-
stabilized reaction chamber positioned on the stage of a microscope
(Axiophot; Zeiss, Oberkochen, Germany) connected to a 16-bit
electron-multiplying charge-coupled device (EM-CCD) camera with
an imaging photon counting system (iXonEM + DU-888; Andor
Technology PLC, Belfast, United Kingdom). Images of the spatial
distribution of light intensities were calibrated by using appropriate
standards. Metabolite concentrations were acquired exclusively from
histologically viable tissue by interactive optical microdissection. The
concentrations were calculated in micromoles per gram of tumor tissue
and were displayed in color-coded images. Three sections per metabo-
lite were analyzed for each tumor, and the mean value was used as a
parameter for the metabolite concentration of a tumor. Further meth-
odological details and representative calibration curves have been
reported elsewhere [15,39].
Assessment of Metastatic Status
Spontaneous metastasis was studied as described elsewhere [27].
Briefly, tumor-bearing mice were killed and examined for external
lymph node metastases in the inguinal, axillary, interscapular, and
submandibular regions and internal lymph node metastases in the
abdomen and mediastinum. The presence of metastatic growth in
enlarged lymph nodes was confirmed by histologic examinations.
Statistical Analysis
Curves were fitted to data by linear regression analysis. Correlations
between variables were searched for by using the Pearson product
moment correlation test. Statistical comparisons of data were carried
out by using the Student’s t test when the data complied with the
conditions of normality and equal variance. Under other conditions,
comparisons were carried out by nonparametric analysis using the
Mann-Whitney rank sum test. The Kolmogorov-Smirnov method
was used to test for normality. Multivariate logistic regression analysis
was used to identify parameters predictive of metastasis. Probability
values (P) and correlation coefficients (R2) were calculated by using
the SigmaStat statistical software. A significance criterion of P < .05
was used.
Results
Eighteen CK-160 and 16 TS-415 tumors were included in the study.
The intratumor heterogeneity in glucose, ATP, and lactate concentra-
tion was significant in both tumor lines. This is illustrated in Figure 1,
which shows the glucose, ATP, and lactate images of a representative
CK-160 tumor (Figure 1A) and a representative TS-415 tumor
(Figure 1B). Furthermore, the glucose, ATP, and lactate concentra-
tions differed substantially among the individual tumors of each line.
This is also illustrated in Figure 1, which shows plots of glucose con-
centration versus ATP concentration, glucose concentration versus
lactate concentration, and ATP concentration versus lactate concen-
tration for the 18 CK-160 tumors (Figure 1C ) and the 16 TS-415
tumors (Figure 1D). In the CK-160 line, there was a positive cor-
relation between the concentrations of glucose and ATP (P =
.0010), an inverse correlation between the concentrations of glucose
and lactate (P = .0058), and no correlation between the concentra-
tions of ATP and lactate (P > .05). However, there was no correlation
between these metabolic parameters in the TS-415 line.
The tumors of both lines showed highly heterogeneous staining
for pimonidazole (Figure 2A). The staining patterns were consistent
with staining of hypoxic cells without staining of normoxic cells.
Positive staining of cells adjacent to blood vessels could not be de-
tected in any of the lines. Necrotic regions were always encompassed
by a rim of pimonidazole-positive cells, a feature that was particularly
pronounced in the TS-415 tumors, which showed a histologic appear-
ance characterized by bands of viable tissue surrounding relatively
large necroses. Foci of pimonidazole-positive cells scattered through-
out the tissue were seen in tumor regions without necrosis. These foci
differed substantially in size and shape, and a few necrotic or necro-
tizing cells could be observed in the middle of some of the foci. Stain-
ing intensity gradients were seen in some CK-160 tumors, whereas
the boundary line between stained and unstained cells was sharp in
most TS-415 tumors.
Fraction of hypoxic tissue (HFPim) differed from 23% to 53%
among the 18 CK-160 tumors and from 8% to 39% among the
16 TS-415 tumors. The intertumor heterogeneity in IFP was also
significant. IFP differed from 2.5 to 31.2 mm Hg (CK-160) and
from 11.3 to 64.5 mm Hg (TS-415). None of the lines showed a
significant correlation between HFPim and IFP (data not shown).
There was a positive correlation between HFPim and lactate con-
centration (P = .0078), an inverse correlation between HFPim and
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glucose concentration (P = .030), and no correlation between HFPim
and ATP concentration (P > .05) in the CK-160 tumors (Figure 2B).
Similarly, the TS-415 tumors showed a positive correlation between
HFPim and lactate concentration (P = .0041), a trend toward an
inverse correlation between HFPim and glucose concentration (P =
.084), and no correlation between HFPim and ATP concentration
(P > .05; Figure 2C ). There was no correlation between IFP and these
metabolic parameters in any of the lines (data not shown).
Figure 1. Glucose, ATP, and lactate concentration images of a representative CK-160 tumor (A) and a representative TS-415 tumor (B) as
measured by imBI and plots of glucose concentration versus ATP concentration, glucose concentration versus lactate concentration,
and ATP concentration versus lactate concentration for CK-160 (C) and TS-415 (D) tumors. Points represent single tumors. Curves were
fitted to data by linear regression analysis.
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Lymph node metastases were detected in 9 of the 18 mice bearing
CK-160 tumors and in 9 of the 16 mice bearing TS-415 tumors,
whereas the other mice were metastasis-negative. In the CK-160
line, the metastatic tumors showed higher HFPim (P = .00028)
and higher lactate concentration (P = .016) than the nonmetastatic
tumors but did not differ from the nonmetastatic tumors in IFP
(P > .05), glucose concentration (P > .05), and ATP concentration
(P > .05; Figure 3A). In the TS-415 line, the metastatic tumors
showed higher IFP (P = .011) and higher lactate concentration
(P = .017) than the nonmetastatic tumors but did not differ from
the nonmetastatic tumors in HFPim (P > .05), glucose concen-
tration (P > .05), and ATP concentration (P > .05; Figure 3B).
Multivariate statistical analysis showed that only HFPim was pre-
dictive of metastasis in CK-160 tumors (P < .001) and that IFP
and lactate concentration were independent predictors of metastasis
in TS-415 tumors (P < .05).
Representative DCE-MRI data are presented in Figure 4, which
shows the K trans image, K trans frequency distribution, ve image, and
ve frequency distribution of a CK-160 tumor with a relatively low
HFPim of 28% (Figure 4A), a TS-415 tumor with a relatively low
HFPim of 16% (Figure 4B), a CK-160 tumor with a relatively
high HFPim of 50% (Figure 4C ), and a TS-415 tumor with a rela-
tively high HFPim of 39% (Figure 4D). The tumors of both lines
were highly heterogeneous in K trans with the highest values in the
periphery and the lowest values in central regions. The intratumor
heterogeneity in ve was also substantial but did not follow a fixed
pattern in any of the lines (i.e., low and high values were seen in the
center as well as in the periphery of the tumors). Furthermore, both
tumor lines showed substantial intertumor heterogeneity in K trans
and ve, but a significant correlation between K
trans and ve was not
seen in any of the lines (data not shown).
Figure 5 shows plots of K trans versus HFPim and the concentrations
of lactate and glucose for the 18 CK-160 tumors (Figure 5A) and the
16 TS-415 tumors (Figure 5B). In both lines, there was an inverse
correlation between K trans and HFPim [P = .000061 (CK-160); P =
.000093 (TS-415)] and between K trans and lactate concentration [P =
.00032 (CK-160); P = .0020 (TS-415)] and a positive correlation
between K trans and glucose concentration [P = .00055 (CK-160); P =
.026 (TS-415)]. However, K trans did not correlate with IFP or ATP
concentration in any of the lines, and furthermore, none of the lines
showed a correlation between ve and HFPim, IFP, or the concentration
of lactate, glucose, or ATP (data not shown).
In the CK-160 line, K trans was higher in the tumors of the metastasis-
negative mice than in the tumors of the metastasis-positive mice
Figure 2. Representative immunohistochemical preparations of a CK-160 tumor and a TS-415 tumor stained with anti-pimonidazole
antibody to visualize hypoxic tissue (A) and plots of HFPim versus lactate, glucose, and ATP concentrations for CK-160 (B) and TS-415
(C) tumors. Points represent single tumors. Curves were fitted to data by linear regression analysis.
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(P = .020), whereas ve did not differ between nonmetastatic and
metastatic tumors (P > .05; Figure 6A). In the TS-415 line, however,
nonmetastatic and metastatic tumors did not differ in either K trans
(P > .05) or ve (P > .05; Figure 6B).
Discussion
Methodological Considerations
The potential of DCE-MRI as a method for providing biomarkers
for personalized treatment of cervical cancer cannot be evaluated
properly without increased insight into the physiological microenvi-
ronment, associations between tumor aggressiveness and microenviron-
mental abnormalities, and associations between DCE-MRI–derived
parameters and parameters of the tumor microenvironment. Eighteen
CK-160 and 16 TS-415 tumors were included in this study, and
K trans, ve, IFP, HFPim, metastatic status, and the concentrations of
lactate, glucose, and ATP were measured in every single tumor. The
strength of this experimental strategy is that it allows direct compar-
isons of data at the individual tumor level, thus avoiding potential
misinterpretations associated with assessing different parameters in
different tumor cohorts.
Tumor IFP was measured before tissue sections were prepared for
assessment of HFPim and lactate, glucose, and ATP concentrations.
The insertion of a Millar catheter into tumors is a rather invasive
procedure, and signs of tissue destruction caused by the catheter were
seen in some tissue sections. To avoid possible artifacts, tissue sections
that were penetrated by the catheter were not used for assessment of
HFPim or metabolite concentrations.
Tumor-bearing mice were scored as either metastasis-positive or
metastasis-negative. A mouse was scored as metastasis-positive only
when histologic examinations could confirm metastatic growth in
at least one lymph node. Attempts to assess the number of positive
lymph nodes were not made. The tumor transplantation site drained
into the ipsilateral inguinal lymph nodes, and these lymph nodes
constituted the principal site of metastatic growth. A mouse was
scored as metastasis-negative when tumor growth could not be
detected by histologic examination of these lymph nodes or any
enlarged lymph node in other sites. This experimental procedure
does not exclude the possibility that tiny metastatic deposits may
have been overlooked and, hence, that metastasis-positive mice erro-
neously may have been scored as metastasis-negative.
Clinical investigations have shown that the intertumor hetero-
geneity of the physiological microenvironment is substantial in locally
advanced cervical carcinoma. Fractions of hypoxic tissue varying from
8% to 95%, IFP values varying from −3 to 48 mm Hg, and lactate
concentrations varying from 2.7 to 15.6 μmol/g have been reported
[10,11,15]. Xenografted tumors of only two cervical carcinoma
lines were included in the present work, which may be a limitation
of our study. However, there are significant reasons to believe that
results obtained with CK-160 and TS-415 tumors are transferable
to the clinical setting. First, the physiological microenvironment
differed substantially also among individual CK-160 and TS-415
tumors, most likely as a consequence of stochastic processes influ-
encing initiation of angiogenesis shortly after tumor cell inoculation.
Interestingly, the intertumor heterogeneity in hypoxic fraction,
IFP, and lactate concentration in CK-160 and TS-415 tumors
was comparable to that reported for cervical carcinomas in humans.
Second, it has been shown that CK-160 and TS-415 xenografts
retain essential biologic properties of the donor patients’ tumors,
including histologic appearance, radiation sensitivity, and meta-
static pattern [27].
Figure 3. HFPim, IFP, and lactate, glucose, and ATP concentrations of nonmetastatic and metastatic CK-160 (A) and TS-415 (B) tumors.
Points represent single tumors. Horizontal bars indicate mean values.
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The Microenvironment of CK-160 and TS-415 Tumors
The energy metabolism of CK-160 tumors differed from that of
TS-415 tumors. Glucose concentration was positively correlated to
ATP concentration and inversely correlated to lactate concentration
in CK-160 tumors but not in TS-415 tumors. It is possible that CK-
160 tumors produce energy primarily from glucose, whereas TS-415
tumors also make significant use of other substrates such as gluta-
mine [40,41]. Significant correlation between the concentrations of
ATP and lactate was not seen in any of the lines, reflecting the gen-
eral observation that cells tend to maintain a constant intracellular
level of ATP during metabolic stress [41].
Tumor hypoxia is primarily a consequence of inadequate blood
supply and increased oxygen consumption [42]. Interstitial hyper-
tension in tumors is mainly a result of high geometric and viscous
resistance to blood flow, low resistance to transcapillary fluid flow,
and impaired lymphatic drainage [11]. Thus, tumor hypoxia and
interstitial hypertension are partly consequences of microvascular
abnormalities and partly consequences of vascular-unrelated abnor-
malities [41]. It has therefore been suggested that the fraction of
hypoxic tissue and IFP may be closely related pathophysiological
parameters in tumors. However, there was no correlation between
HFPim and IFP in the present study, implying that these parameters
are not governed by a common mechanism in CK-160 and TS-415
tumors. This observation is consistent with the clinical observation
that tissue pO2 is not correlated to IFP in cervical carcinoma [11].
As expected, IFP did not correlate with the concentration of lac-
tate, glucose, or ATP in any of the tumor lines. In contrast, HFPim
increased with increasing lactate concentration and decreased with
increasing glucose concentration in both lines. However, the associa-
tions were weak, particularly the associations between hypoxia and
glucose concentration. The concentration of glucose in tumor tissues
is determined primarily by an equilibrium between the rate of glu-
cose supply and the rate of glucose consumption, and similarly, the
concentration of lactate is determined primarily by the rate of cellular
production and the rate of clearance by the vasculature [41]. Tumor
cells may produce lactate from glucose by aerobic as well as anaerobic
glycolysis, and they generally show increased glucose consumption
under hypoxic conditions [41,43]. The associations reported here
Figure 4. K trans image, K trans frequency distribution, ve image, and ve frequency distribution of a CK-160 tumor with a relatively low HFPim
of 28% (A), a TS-415 tumor with a relatively low HFPim of 16% (B), a CK-160 tumor with a relatively high HFPim of 50% (C), and a TS-415
tumor with a relatively high HFPim of 39% (D).
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suggest that lactate is produced primarily by anaerobic glycolysis in
CK-160 and TS-415 tumors, consistent with the observation that
CK-160 and TS-415 cells in culture produce substantially more lac-
tate under hypoxic than under aerobic conditions and the observa-
tion that CK-160 and TS-415 tumors primarily show chronic
hypoxia as opposed to acute or cyclic hypoxia [44].
Associations between lactate concentration and hypoxic fraction
have been searched for in several preclinical studies by comparing
different tumor lines, individual tumors of the same line, and sub-
regions of single tumors, and significant associations were found in
some studies but not in others [45–48]. In general, the concentration
of lactate is unrelated to the extent of hypoxia in tumors showing
increased glycolytic flux [37,39,49]. For example, Yaromina et al.
[48] studied xenografted tumors of three highly glycolytic cell lines
derived from squamous cell carcinomas of the head and neck, ob-
served that the average concentration of lactate did not correlate with
the overall pimonidazole hypoxic fraction in any of the lines, and
concluded that the extent of hypoxia cannot be predicted from the
concentration of lactate. Busk et al. [50] assessed the relative parti-
tioning between glycolytic and mitochondrial ATP synthesis in four
squamous cell carcinoma cell lines, three of head and neck origin and
one of cervical origin, and found that the ATP generation in all lines
established from head and neck tumors relied on aerobic glycolysis,
whereas the line established from a cervical tumor (SiHa) was found
to show predominantly nonglycolytic ATP synthesis. The energy
metabolism of CK-160 and TS-415 cervical carcinomas thus appears
to be similar to that of SiHa cells and different from that of squa-
mous cell carcinomas of the head and neck. Interestingly, it has been
speculated that the glycolytic phenotype may be inherited from the
tissue of tumor origin [50].
Microenvironment-Associated Metastasis in
CK-160 and TS-415 Tumors
Clinical studies have shown that tumor aggressiveness is associated
with severe abnormalities in the tumor microenvironment in cervical
cancer [7–15]. The present preclinical investigation is consistent
with this clinical observation and suggests that an abnormal micro-
environment may promote lymph node metastasis in cervical carci-
noma. Furthermore, our study suggests that different mechanisms
may be involved in different tumors, depending on the nature of
the abnormalities. High lactate concentration was associated with
metastatic dissemination in both tumor lines, and in addition, devel-
opment of metastases was associated with high HFPim in CK-160
tumors and with high IFP in TS-415 tumors. Noteworthy, lymph
Figure 5. Plots of K trans versus HFPim and the concentrations of lactate and glucose for CK-160 (A) and TS-415 (B) tumors. Points rep-
resent single tumors. Curves were fitted to data by linear regression analysis.
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node metastasis was associated with high lactate concentration but
not with high HFPim in TS-415 tumors, suggesting that the differ-
ence between metastatic and nonmetastatic tumors in lactate concen-
tration was not merely a secondary consequence of a difference in
extent of hypoxia.
Hypoxia may facilitate metastasis by inducing genomic instability,
by selecting for aggressive cell phenotypes, and by upregulating the
expression of metastasis-promoting genes [51,52]. Several transcrip-
tion factors are activated by hypoxia including hypoxia-inducible
factor-1 (HIF-1), and targets of HIF-1 play critical roles in many
steps of the metastatic process, including cell viability/apoptosis, cell
proliferation/growth arrest, tissue remodeling/invasion, tissue metab-
olism, and angiogenesis [53]. Elevated lactate levels may promote
metastasis by hypoxia-dependent as well as hypoxia-independent
mechanisms [49]. The hypoxia-independent mechanisms include
lactate-induced stabilization of HIF-1α under normoxic conditions
and lactate-induced activation of signaling pathways that promote
cell migration and invasion [54]. High IFP directs interstitial fluid
from tumors into the surrounding normal tissue, and this fluid
carries proteolytic enzymes, chemokines, and lymphangiogenic fac-
tors that may facilitate lymph node metastasis by remodeling the
extracellular matrix, dilating peritumoral lymphatics, and inducing
lymphangiogenesis in the sentinel lymph node [55,56].
DCE-MRI in Assessment of the Aggressiveness of
Cervical Carcinoma
The K trans of both CK-160 and TS-415 tumors increased with
increasing glucose concentration and decreased with increasing lac-
tate concentration and increasing HFPim. Previous studies have
revealed that HFPim is inversely correlated to the microvascular den-
sity of the viable tissue in CK-160 and TS-415 tumors and that the
microvascular density is higher in TS-415 tumors than in CK-160
tumors [44,57]. Consequently, low values of K trans were associated
with a particularly hostile microenvironment in these tumors. More-
over, K trans was lower in metastatic than in nonmetastatic CK-160
tumors, in accordance with the observation that the metastatic
tumors showed higher HFPim and higher lactate concentration than
the nonmetastatic tumors and the hypothesis that hypoxia and lac-
tate may promote lymph node metastasis in cervical carcinoma. In
contrast, K trans did not differ significantly between metastatic and
nonmetastatic TS-415 tumors, even though the metastatic tumors
showed higher lactate concentration than the nonmetastatic tumors,
possibly because high IFP exerted a stronger influence on the meta-
static potential than did high lactate levels. This suggestion is consis-
tent with the findings that IFP was higher in metastatic than in
nonmetastatic TS-415 tumors and that there was no correlation be-
tween K trans and IFP.
Several studies of cervical carcinoma have revealed weak but signif-
icant correlations between DCE-MRI–derived parameters and out-
come of treatment. However, poor prognosis was associated with
high signal enhancement in some studies and with low signal
enhancement in others [20–23]. Poor correlations and conflicting
results may reflect that the analyses were based on semiquantitative
DCE-MRI parameters rather than quantitative parameters calculated
by the use of pharmacokinetic models. For low-molecular-weight
contrast agents like Gd-DTPA, low K trans values indicate poor
blood supply and are associated with low signal enhancement [32].
The present study thus suggests that low signal enhancement rather
than high signal enhancement is indicative of poor prognosis in
cervical carcinoma.
More importantly, the present study suggests that K trans may be a
significant predictive factor in cervical carcinoma. It can be hypo-
thesized from our preclinical data that K trans may discriminate well
between tumors with severe and less severe microenvironmental
abnormalities also in the clinical setting and, moreover, that K trans
may be developed to be a robust biomarker for tumor aggressiveness.
This hypothesis deserves to be tested in comprehensive clinical inves-
tigations, and if found to be valid, it opens for the possibility that
patients with low-K trans tumors may be given highly aggressive
concurrent radiochemotherapy, whereas patients with high-K trans
tumors may be spared for the side effects of aggressive treatment.
Even though K trans may be useful for identifying particularly
aggressive cervical carcinomas, pharmacokinetic analysis of DCE-MRI
data is not sufficient to establish whether aggressiveness is primarily a
consequence of extensive hypoxia, highly elevated IFP, or high lac-
tate concentrations. To provide specific information on the physio-
logical microenvironment of cervical carcinomas for targeted
treatment strategies, supplementary MRI data are required. Particu-
larly promising strategies include the use of blood oxygenation level–
dependent MRI for assessment of tumor hypoxia [58], peritumoral
fluid flow velocity DCE-MRI for assessment of IFP [59], and spec-
troscopic MRI for assessment of lactate levels [60].
In summary, low K trans was associated with high hypoxic fraction,
low glucose concentration, and high lactate concentration in human
cervical carcinoma xenografts, and metastatic tumors showed high
lactate concentrations in combination with either high hypoxic frac-
tions or highly elevated IFP. These observations suggest that K trans
may be useful for characterizing the physiological microenvironment
Figure 6. K trans and ve of nonmetastatic and metastatic CK-160 (A)
and TS-415 (B) tumors. Points represent single tumors. Horizontal
bars indicate mean values.
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of cervical carcinomas and, hence, a useful biomarker for micro-
environment-induced tumor aggressiveness and treatment resistance.
This possibility should be investigated thoroughly in prospective
clinical studies.
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